Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccines.

A Lee1

  • 1School of Microbiology and Immunology, The University of New South Wales, Sydney, Australia. A.Lee@unsw.edu.au

European Journal of Gastroenterology & Hepatology
|September 30, 1999
PubMed
Summary
This summary is machine-generated.

Developing a vaccine against Helicobacter pylori infection is a key research goal. Shifting the immune response from Th1 to Th2 may offer a therapeutic strategy for H. pylori-associated diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hello and goodbye: a study of social engagement in autism.

Journal of autism and developmental disorders·1998
Same author

Respiratory ultrasonography of human parasternal intercostal muscle in vivo.

Ultrasound in medicine & biology·1998
Same author

Negative reexploration for cardiac postoperative bleeding: can it be therapeutic?

The Annals of thoracic surgery·1998
Same author

The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure.

Hepatology (Baltimore, Md.)·1998
Same author

Localization of alpha2C-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system.

Neuroscience·1998
Same author

Intestinal tuberculosis: clinicopathologic analysis and diagnosis by endoscopic biopsy.

The American journal of gastroenterology·1998
Same journal

Comment on 'Associations between 12 insulin resistance surrogates with metabolic dysfunction-associated steatotic liver disease risk and all-cause mortality: data from the National Health and Nutrition Examination Survey III (1988-1994)'.

European journal of gastroenterology & hepatology·2026
Same journal

Alarm symptoms at diagnosis of coeliac disease and long-term outcomes.

European journal of gastroenterology & hepatology·2026
Same journal

Artificial intelligence-integrated nanotherapeutics for rare Peutz-Jeghers syndrome hamartoma-induced obstructions: latest clearance strategies.

European journal of gastroenterology & hepatology·2026
Same journal

'Presence of alarm symptoms at coeliac disease diagnosis is not associated with poorer long-term treatment outcomes' [Letter].

European journal of gastroenterology & hepatology·2026
Same journal

Atrial fibrillation in patients with alcohol-associated hepatitis leads to increased mortality.

European journal of gastroenterology & hepatology·2026
Same journal

Association between albumin-bilirubin score, model for end-stage liver disease score, platelet-albumin-bilirubin score, and acute-on-chronic liver failure complications: a cross-sectional study in a Chinese population.

European journal of gastroenterology & hepatology·2026
See all related articles

Area of Science:

  • Immunology
  • Microbiology
  • Vaccinology

Background:

  • Helicobacter pylori infection is a persistent global health challenge.
  • Current immunization strategies show promise in animal models, including mice and ferrets.
  • Developing an effective human vaccine against H. pylori is a major research objective.

Purpose of the Study:

  • To explore the role of T-helper cell phenotypes (Th1 and Th2) in H. pylori immunity.
  • To investigate the potential of modulating the Th1/Th2 balance for therapeutic benefit.
  • To assess the feasibility of developing anti-Helicobacter vaccines for human use.

Main Methods:

  • Review of existing research on H. pylori immunization and immune responses.
  • Analysis of the roles of Th1 (cell-mediated) and Th2 (antibody-mediated) lymphocytes.

Related Experiment Videos

  • Examination of studies involving genetically modified mice with altered cytokine profiles.

    • Main Results:

    • H. pylori infection often elicits a Th1 response in humans, which is insufficient for eradication.
    • A Th2 response, promoting antibody production (IgA, IgG) at mucosal surfaces, is hypothesized to be more effective.
    • Mouse studies suggest that altering the Th1/Th2 balance may yield therapeutic effects.

    Conclusions:

    • A shift towards a Th2-dominant immune response could be a viable strategy for H. pylori vaccines.
    • Human trials for anti-Helicobacter vaccines are anticipated within the next 2-5 years.
    • These upcoming vaccines represent a novel approach to managing gastroduodenal diseases caused by H. pylori.